Zura Bio Ltd (NASDAQ: ZURA) kicked off on Monday, up 4.39% from the previous trading day, before settling in for the closing price of $2.28. Over the past 52 weeks, ZURA has traded in a range of $2.00-$6.35.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
While this was happening, its average annual earnings per share was recorded 68.12%. With a float of $47.46 million, this company’s outstanding shares have now reached $65.29 million.
Let’s determine the extent of company efficiency that accounts for 15 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Zura Bio Ltd (ZURA) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Zura Bio Ltd is 27.32%, while institutional ownership is 53.60%. The most recent insider transaction that took place on Nov 25 ’24, was worth 2,734,458. In this transaction Director of this company sold 1,001,633 shares at a rate of $2.73, taking the stock ownership to the 0 shares. Before that another transaction happened on Sep 11 ’24, when Company’s Director sold 3,800,000 for $2.70, making the entire transaction worth $10,260,000. This insider now owns 1,001,633 shares in total.
Zura Bio Ltd (ZURA) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 68.12% per share during the next fiscal year.
Zura Bio Ltd (NASDAQ: ZURA) Trading Performance Indicators
Take a look at Zura Bio Ltd’s (ZURA) current performance indicators. Last quarter, stock had a quick ratio of 10.36.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.59, a number that is poised to hit -0.16 in the next quarter and is forecasted to reach -0.74 in one year’s time.
Technical Analysis of Zura Bio Ltd (ZURA)
Looking closely at Zura Bio Ltd (NASDAQ: ZURA), its last 5-days average volume was 0.89 million, which is a jump from its year-to-date volume of 0.35 million. As of the previous 9 days, the stock’s Stochastic %D was 26.20%. Additionally, its Average True Range was 0.28.
During the past 100 days, Zura Bio Ltd’s (ZURA) raw stochastic average was set at 7.88%, which indicates a significant decrease from 28.40% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 103.32% in the past 14 days, which was higher than the 82.49% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.57, while its 200-day Moving Average is $3.76. However, in the short run, Zura Bio Ltd’s stock first resistance to watch stands at $2.52. Second resistance stands at $2.66. The third major resistance level sits at $2.83. If the price goes on to break the first support level at $2.21, it is likely to go to the next support level at $2.05. Should the price break the second support level, the third support level stands at $1.91.
Zura Bio Ltd (NASDAQ: ZURA) Key Stats
The company with the Market Capitalisation of 155.40 million has total of 65,294K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -69,240 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -22,940 K.
